[go: up one dir, main page]

LV10579A - Farmaceitiska kompozicija - Google Patents

Farmaceitiska kompozicija

Info

Publication number
LV10579A
LV10579A LV940151A LV940151A LV10579A LV 10579 A LV10579 A LV 10579A LV 940151 A LV940151 A LV 940151A LV 940151 A LV940151 A LV 940151A LV 10579 A LV10579 A LV 10579A
Authority
LV
Latvia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
LV940151A
Other languages
English (en)
Other versions
LV10579B (en
Inventor
Ferenc Ender
Jozsef Furesz
Laszlo Rosivall
Katalin Schweitzer
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LV10579A publication Critical patent/LV10579A/lv
Publication of LV10579B publication Critical patent/LV10579B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-94-151A 1993-08-02 1994-07-29 Pharmaceutical composition LV10579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9302229A HUT68560A (en) 1993-08-02 1993-08-02 The use of xantine derivatives for promotion of healing of operative lesions

Publications (2)

Publication Number Publication Date
LV10579A true LV10579A (lv) 1995-04-20
LV10579B LV10579B (en) 1995-10-20

Family

ID=10983853

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-151A LV10579B (en) 1993-08-02 1994-07-29 Pharmaceutical composition

Country Status (11)

Country Link
US (1) US5516778A (lv)
EP (1) EP0640342A3 (lv)
JP (1) JPH07145059A (lv)
KR (1) KR950005307A (lv)
CA (1) CA2129274A1 (lv)
CZ (1) CZ185394A3 (lv)
HU (1) HUT68560A (lv)
LV (1) LV10579B (lv)
RU (1) RU94028283A (lv)
SK (1) SK92194A3 (lv)
ZA (1) ZA945752B (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
WO1998029127A1 (en) * 1995-10-06 1998-07-09 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
EP2265334A2 (en) 2008-02-29 2010-12-29 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
JP2015512947A (ja) 2012-04-13 2015-04-30 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20170216296A1 (en) 2014-04-18 2017-08-03 Concert Pharmaceuticals, Inc. Methods of treating hyperglycemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient

Also Published As

Publication number Publication date
ZA945752B (en) 1995-10-25
JPH07145059A (ja) 1995-06-06
EP0640342A3 (en) 1995-04-19
LV10579B (en) 1995-10-20
CA2129274A1 (en) 1995-02-03
SK92194A3 (en) 1995-03-08
HU9302229D0 (en) 1993-10-28
CZ185394A3 (en) 1995-02-15
RU94028283A (ru) 1996-08-27
KR950005307A (ko) 1995-03-20
US5516778A (en) 1996-05-14
EP0640342A2 (en) 1995-03-01
HUT68560A (en) 1995-04-27

Similar Documents

Publication Publication Date Title
FI944832A (fi) Farmaseuttinen koostumus
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
NO20004345L (no) Farmasøytisk sammensetning
FI941663A (fi) Trikriittisen pisteen omaava koostumus
ITMI932540A0 (it) Composizione farmaceutica
MX9200622A (es) Composicion farmaceutica
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
FI955605A0 (fi) Aryloivia lääkkeitä
FI973280A0 (fi) Farmaseuttinen koostumus
NO961589D0 (no) Farmasöytiske blandinger
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
KR950703340A (ko) 항엠알에스에이 조성물
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
BR1100200A (pt) Composição farmacêutica
ITMI932543A0 (it) Composizione farmaceutica
SE9402924D0 (sv) Novel pharmaceutical composition
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI922581A1 (it) Composizione farmaceutica
ITMI922580A1 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition